The 7 analysts offering 12-month price forecasts for Stoke Therapeutics Inc have a median target of 18.00, with a high estimate of 35.00 and a low estimate of 6.00. The median estimate represents a +278.15% increase from the last price of 4.76.
The current consensus among 9 polled investment analysts is to Buy stock in Stoke Therapeutics Inc. This rating has held steady since November, when it was unchanged from a Buy rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share -$0.66
Reporting Date Mar 06
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.